BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 3677044)

  • 41. Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors.
    Ueki K; Nishikawa R; Nakazato Y; Hirose T; Hirato J; Funada N; Fujimaki T; Hojo S; Kubo O; Ide T; Usui M; Ochiai C; Ito S; Takahashi H; Mukasa A; Asai A; Kirino T
    Clin Cancer Res; 2002 Jan; 8(1):196-201. PubMed ID: 11801559
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phenotype versus genotype correlation in oligodendrogliomas and low-grade diffuse astrocytomas.
    Watanabe T; Nakamura M; Kros JM; Burkhard C; Yonekawa Y; Kleihues P; Ohgaki H
    Acta Neuropathol; 2002 Mar; 103(3):267-75. PubMed ID: 11907807
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genomic characterization of ependymomas reveals 6q loss as the most common aberration.
    Olsen TK; Gorunova L; Meling TR; Micci F; Scheie D; Due-Tønnessen B; Heim S; Brandal P
    Oncol Rep; 2014 Aug; 32(2):483-90. PubMed ID: 24939246
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Flow cytometric analysis of cellular DNA content in human astrocytomas and oligodendrogliomas.
    Ahyai A
    Neurosurg Rev; 1988; 11(2):177-87. PubMed ID: 3244416
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CDKN2/p16 predicts survival in oligodendrogliomas: comparison with astrocytomas.
    Miettinen H; Kononen J; Sallinen P; Alho H; Helen P; Helin H; Kalimo H; Paljärvi L; Isola J; Haapasalo H
    J Neurooncol; 1999 Feb; 41(3):205-11. PubMed ID: 10359140
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Karyotype analyses of 20 human glioma cell lines.
    Westphal M; Hänsel M; Hamel W; Kunzmann R; Hölzel F
    Acta Neurochir (Wien); 1994; 126(1):17-26. PubMed ID: 8154317
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nogo-a expression in glial CNS tumors: a tool to differentiate between oligodendrogliomas and other gliomas?
    Kuhlmann T; Gutenberg A; Schulten HJ; Paulus W; Rohde V; Bruck W
    Am J Surg Pathol; 2008 Oct; 32(10):1444-53. PubMed ID: 18685489
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytogenetic abnormalities in human ependymomas.
    Stratton MR; Darling J; Lantos PL; Cooper CS; Reeves BR
    Int J Cancer; 1989 Oct; 44(4):579-81. PubMed ID: 2793229
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Histological and molecular classification of gliomas].
    Figarella-Branger D; Colin C; Coulibaly B; Quilichini B; Maues De Paula A; Fernandez C; Bouvier C
    Rev Neurol (Paris); 2008; 164(6-7):505-15. PubMed ID: 18565348
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Loss of heterozygosity of chromosome 1p/19q and p53 protein expression in oligodendroglioma].
    Xiong J; Liu Y; Li C; Zhu JJ; Ye ZR; Mao Y; Wang Y
    Zhonghua Bing Li Xue Za Zhi; 2009 Jul; 38(7):445-50. PubMed ID: 19781190
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Utility of EGFR and PTEN numerical aberrations in the evaluation of diffusely infiltrating astrocytomas. Laboratory investigation.
    Mott RT; Turner KC; Bigner DD; McLendon RE
    J Neurosurg; 2008 Feb; 108(2):330-5. PubMed ID: 18240930
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular Signatures of Chromosomal Instability Correlate With Copy Number Variation Patterns and Patient Outcome in IDH-Mutant and IDH-Wildtype Astrocytomas.
    Richardson TE; Sathe AA; Xing C; Mirchia K; Viapiano MS; Snuderl M; Abdullah KG; Hatanpaa KJ; Walker JM
    J Neuropathol Exp Neurol; 2021 Mar; 80(4):354-365. PubMed ID: 33755138
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genomic aberrations in diffuse low-grade gliomas.
    Dahlback HS; Gorunova L; Brandal P; Scheie D; Helseth E; Meling TR; Heim S
    Genes Chromosomes Cancer; 2011 Jun; 50(6):409-20. PubMed ID: 21412929
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of 1p/19q Codeletion and Radiation Necrosis in Adult Cranial Gliomas After Proton or Photon Therapy.
    Acharya S; Robinson CG; Michalski JM; Mullen D; DeWees TA; Campian JL; Chundury A; Bottani B; Hallahan DE; Bradley JD; Huang J
    Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):334-343. PubMed ID: 29534896
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chromosomes in the genesis and progression of ependymomas.
    Rogatto SR; Casartelli C; Rainho CA; Barbieri-Neto J
    Cancer Genet Cytogenet; 1993 Sep; 69(2):146-52. PubMed ID: 8402555
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recurrent gain of chromosome arm 7q in low-grade astrocytic tumors studied by comparative genomic hybridization.
    Schröck E; Blume C; Meffert MC; du Manoir S; Bersch W; Kiessling M; Lozanowa T; Thiel G; Witkowski R; Ried T; Cremer T
    Genes Chromosomes Cancer; 1996 Apr; 15(4):199-205. PubMed ID: 8703845
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Specific chromosomal imbalances as detected by array CGH in ependymomas in association with tumor location, histological subtype and grade.
    Rousseau A; Idbaih A; Ducray F; Crinière E; Fèvre-Montange M; Jouvet A; Delattre JY
    J Neurooncol; 2010 May; 97(3):353-64. PubMed ID: 19865800
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Histological grading of gliomas.
    Daumas-Duport C
    Curr Opin Neurol Neurosurg; 1992 Dec; 5(6):924-31. PubMed ID: 1334739
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cytogenetics of pediatric central nervous system tumors.
    Sainati L; Bolcato S; Montaldi A; Celli P; Stella M; Leszl A; Silvestro L; Perilongo G; Cordero di Montezemolo L; Basso G
    Cancer Genet Cytogenet; 1996 Oct; 91(1):13-27. PubMed ID: 8908162
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Accumulation of genetic changes is associated with poor prognosis in grade II astrocytomas.
    Sallinen SL; Sallinen P; Haapasalo H; Kononen J; Karhu R; Helén P; Isola J
    Am J Pathol; 1997 Dec; 151(6):1799-807. PubMed ID: 9403731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.